Sign In
Buy CANF
$3.12
+0.0100 (+0.322%)
At Close: Jun 03, 2026
Can-Fite Posts $9.6M Net Loss, Provides Clinical Trials Updates
12:00am, Friday, 27'th Mar 2020BMY, TLRY among premarket gainers
01:21pm, Monday, 23'rd Mar 2020
Waitr Holdings (NASDAQ:WTRH) +51% on expanding into Grocery Delivery.Innate Pharma S.A. (NASDAQ:IPHA) +34% on potential use of cancer drug for Covid-19.DCP Midstream, LP (NYSE:DCP) +31% on cutting
Can-Fite: Piclidenoson is Submitted for Compassionate Use Treatment for Coronavirus Patients in Israel
11:45am, Monday, 23'rd Mar 2020
Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced today
Can-Fite Submits its Piclidenoson for Compassionate Use Treatment for Coronavirus Patients in Israel
12:00am, Monday, 23'rd Mar 2020SLS, APRN among premarket gainers
01:23pm, Wednesday, 18'th Mar 2020
Biomerica (NASDAQ:BMRA) +133% on advancement of rapid coronavirus test.IMV (NASDAQ:IMV) +55% on coronavirus vaccine plan.Vaxart (NASDAQ:VXRT) +46% on coronavirus vaccine deal.Blue Apron Holdings (N
Can-Fite to Participate in Digital Bio-Europe Spring Partnering Conference; Looks to Partner on Co-Development for Coronavirus Treatment
Can-Fite: Progress in Compassionate Use Program Treating Advanced Liver Cancer Patients with Namodenoson
11:00am, Monday, 16'th Mar 2020
Can-Fite: Progress in Compassionate Use Program Treating Advanced Liver Cancer Patients with Namodenoson
The Week In Cannabis: Coronavirus Drop, Major Financing Agreements, Psychedelics Getting Hot
12:53pm, Saturday, 14'th Mar 2020
This was another brutal week for cannabis stocks, with all major ETFs posting double-digits losses. Over the last five trading days: The ETFMG Alternative Harvest ETF (NYSE: MJ ) lost 13.7%. The Advis
The Latest Coronavirus Developments From Biotechs: La Jolla Provides Giapreza In Italy, Enanta Researches Antivirals
02:53pm, Friday, 13'th Mar 2020
The following are the latest biotech announcements from late Thursday and Friday morning on the development of products targeting the coronavirus.
I-Mab ADR (NASDAQ: IMAB)...
OXY, NRZ among premarket gainers
01:25pm, Friday, 13'th Mar 2020
OPKO Health (NASDAQ:OPK) +45% as subsidiary BioReference Laboratories is now accepting samples for COVID-19. Liberty TripAdvisor Holdings (NASDAQ:LTRPA) +43%.Norwegian Cruise Line Holdings (NYSE:N
30 Stocks Moving in Friday's Pre-Market Session
11:32am, Friday, 13'th Mar 2020
Gainers
Can-Fite BioPharma Ltd. (NYSE: CANF) rose 56.3% to $2.00 in pre-market trading after declining over 12% on Thursday.
Intec Pharma Ltd. (NASDAQ: NTEC) rose 40% to $0.28...
Benzinga Pro's Top 5 Stocks To Watch For Fri., Mar. 13, 2020: GLD, OPK, IBIO, CPB, CANF
12:00am, Friday, 13'th Mar 2020Biotech Stock Roundup: NVAX, CANF Up on Coronavirus Treatment Updates & More
03:06pm, Wednesday, 11'th Mar 2020
The biotech sector is in focus with pipeline updates from companies evaluating treatments for the novel COVID-19.
INO, DXC among premarket gainers
01:16pm, Wednesday, 11'th Mar 2020
Tiziana Life Sciences PLC (NASDAQ:TLSA) +162% on potential coronavirus treatment.Phio Pharmaceuticals (NASDAQ:PHIO) +24% on Medigene deal.Inovio Pharmaceuticals (NASDAQ:INO) +21%.Altimmune (NASDAQ:A
